Research output
- 4 Article
-
Long-Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real-World Multicentric Case Series
Bangert, C., Ebner, B., Gruber, B., Meyersburg, D. & Traxler, J., Feb 2026, In: International journal of dermatology. 65, 2, p. 347-349 3 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Personalized biologic treatments for patients with Darier disease result in varying responses
Ettinger, M., Burner, T., Lackner, A., Deli, I., Traxler, J., Altrichter, S., Gratz, I. K., Kimeswenger, S., Guenova, E. & Hoetzenecker, W., Mar 2026, In: Journal of the European Academy of Dermatology and Venerology. 40, 3, p. 513-516 4 p.Research output: Contribution to journal › Article › peer-review
-
Darier disease: Current insights and challenges in pathogenesis and managemen
Ettinger, M., Kimeswenger, S., Deli, I. M., Traxler, J., Altrichter, S., Noack, P., Wikstrom, J. D., Guenova, E. & Hötzenecker, W., Oct 2024, In: Journal of the European Academy of Dermatology and Venerology. 39, 5, p. 942-951 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets
Ettinger, M., Burner, T., Sharma, A., Chang, Y.-T., Lackner, A., Prompsy, P., Deli, I. M., Traxler, J., Wahl, G., Altrichter, S., Langer, R., Tsai, Y.-C., Varkhande, S. R., Schoeftner, L. C., Iselin, C., Gratz, I., Kimeswenger, S., Guenova, E. & Hoetzenecker, W., 17 Nov 2023, In: Nature Communications. 14, 1, 10 p., 7470.Research output: Contribution to journal › Article › peer-review
Open Access
-
Neues zu Nemolizumab und JAK-Inhibitoren
Traxler, J. (Speaker)
10 Sept 2025Activity: Talk or presentation › Other talk or presentation › science-to-public
-
Ein Fall für 3: Derma, Rheuma, Onko
Traxler, J. (Speaker)
31 May 2025Activity: Talk or presentation › Other talk or presentation › science-to-public
-
HIV-Postexpositionsprophylaxe
Traxler, J. (Speaker)
28 Nov 2023Activity: Talk or presentation › Contributed talk › science-to-science